FITB
50
2
NVDA
50
4
PCAR
36
12
BRK.B
42
6
ADT
53
3
CAH
54
6
ECL
37
3
BF.B
50
4
VRTX
49
3
ZTS
16
6
INTU
60
6
DVA
65
3
HSIC
47
3
CHRW
56
2
MTCH
17
4
PHM
48
2
DHI
35
4
GME
86
6
PRU
47
2
EIX
42
3
FITB
50
2
NVDA
50
4
PCAR
36
12
BRK.B
42
6
ADT
53
3
CAH
54
6
ECL
37
3
BF.B
50
4
VRTX
49
3
ZTS
16
6
INTU
60
6
DVA
65
3
HSIC
47
3
CHRW
56
2
MTCH
17
4
PHM
48
2
DHI
35
4
GME
86
6
PRU
47
2
EIX
42
3
Financhill
Back

Krystal Biotech Stock Price Chart

Former Zillow execs target $1.3T market

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
51

KRYS
Krystal Biotech

Last Price:
$168.79
Seasonality Move:
21.08%

7 Day Trial

ALL ACCESS PASS

$ 7

The key to a $1.3T opportunity

This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KRYS is experiencing buying pressure, which is a positive indicator for future bullish movement.

Krystal Biotech Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 168.62 Sell
20-day SMA: 179.23 Sell
50-day SMA: 172.82 Sell
200-day SMA: 179.22 Sell
8-day EMA: 168.12 Sell
20-day EMA: 173.84 Sell
50-day EMA: 173.61 Sell
200-day EMA: 170.63 Sell

Krystal Biotech Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.46 Sell
Relative Strength Index (14 RSI): 42.18 Sell
Chaikin Money Flow: 275228 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (169.82 - 188.94) Sell
Bollinger Bands (100): (156.42 - 185) Sell

Krystal Biotech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Krystal Biotech Stock

Is Krystal Biotech Stock a Buy?

  • Krystal Biotech share price is 165.00 while KRYS 8-day simple moving average is 168.62, which is a Sell signal.
  • The stock price of KRYS is 165.00 while Krystal Biotech 20-day SMA is 179.23, which makes it a Sell.
  • Krystal Biotech 50-day simple moving average is 172.82 while KRYS share price is 165.00, making it a Sell technically.
  • KRYS stock price is 165.00 and Krystal Biotech 200-day simple moving average is 179.22, creating a Sell signal.

KRYS Technical Analysis vs Fundamental Analysis

Buy
51
Krystal Biotech (KRYS) is a Buy

Is Krystal Biotech a Buy or a Sell?

  • Krystal Biotech stock is rated a Buy
    The current Krystal Biotech [KRYS] share price is $165.00. The Score for KRYS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.

Krystal Biotech Stock Info

Market Cap:
4.8B
Price in USD:
165.00
Share Volume:
426.7K

Krystal Biotech 52-Week Range

52-Week High:
219.34
52-Week Low:
141.72
Buy
51
Krystal Biotech (KRYS) is a Buy

Krystal Biotech Share Price Forecast

Is Krystal Biotech Stock a Buy?

  • Krystal Biotech share price is 165.00 while KRYS 8-day exponential moving average is 168.12, which is a Sell signal.
  • The stock price of KRYS is 165.00 while Krystal Biotech 20-day EMA is 173.84, which makes it a Sell.
  • Krystal Biotech 50-day exponential moving average is 173.61 while KRYS share price is 165.00, making it a Sell technically.
  • KRYS stock price is 165.00 and Krystal Biotech 200-day simple moving average is 170.63, creating a Sell signal.

Fundamental Analysis of Krystal Biotech

Is Krystal Biotech a good investment?

  • Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.41 per share, and an increase next year of $3.19 per share.

Technical Analysis of Krystal Biotech

Should I short Krystal Biotech stock?

* Krystal Biotech stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.